Like IMU, IND trial approval at first time after submitting. That's proof of how experienced Team CHM / IMU is and is in line with the exceptional safety records of technologies licenced by PH's companies. Now bring on efficacy.
Well done CHM.
GLTA
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.07M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.26K | 2.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4309921 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 14960701 | 24 |
View Market Depth
| Last trade - 14.55pm 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |